the B-O B-A1
production B-O I-A1
of B-O I-A1
c51 B-O I-A1
microcin B-O I-A1
has B-O O
#decreased B-O B-V
or B-O O
been B-O O
absent B-O O
in B-O O
rpos B-O B-A2
, B-O I-A2
crp B-O I-A2
and B-O I-A2
cya B-O I-A2
mutant B-O I-A2
cells B-O I-A2
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
could B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
the B-O B-A1
production B-O I-A1
of B-O I-A1
c51 B-O I-A1
microcin B-O I-A1
was B-O O
shown B-O O
to B-O O
#decrease B-O B-V
or B-O O
be B-O O
absent B-O O
in B-O O
rpos B-O B-A2
, B-O I-A2
crp B-O I-A2
and B-O I-A2
cya B-O I-A2
mutant B-O I-A2
cells B-O I-A2
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
would B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O I-A0
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
is B-O O
shown B-O O
to B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
, B-O O
and B-O O
permits B-O O
a B-O O
recovery B-O O
of B-O I-A0
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
the B-O B-A1
production B-O I-A1
of B-O I-A1
c51 B-O I-A1
microcin B-O I-A1
is B-O O
believed B-O O
to B-O O
#decrease B-O B-V
or B-O O
be B-O O
absent B-O O
in B-O O
rpos B-O B-A2
, B-O I-A2
crp B-O I-A2
and B-O I-A2
cya B-O I-A2
mutant B-O I-A2
cells B-O I-A2
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
can B-O O
have B-O O
#decreased B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
the B-O O
levels B-O B-A1
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
might B-O O
be B-O O
#decreased B-O B-V
in B-O O
nlf B-O O
from B-O O
smokers B-O O
, B-O O
and B-O O
it B-O O
has B-O O
also B-O O
been B-O O
found B-O O
that B-O O
nlf B-O O
from B-O O
smokers B-O O
contained B-O O
increased B-O O
proportions B-O O
of B-O O
a B-O O
truncated B-O O
variant B-O O
of B-O O
lipocortin-1 B-O O
, B-O O
threee B-O O
acidic B-O O
forms B-O O
of B-O O
alpha B-O O
(1)-antitrypsin B-O O
, B-O O
and B-O O
one B-O O
phosphorylated B-O O
form B-O O
of B-O O
cystatin B-O O
s B-O O
.syntrophin B-O O
binds B-O O
to B-O O
an B-O O
alternatively B-O O
spliced B-O O
exon B-O O
of B-O O
dystrophin B-O O
. B-O O
  
if B-O O
this B-O O
distance B-O O
of B-O O
30 B-O O
amino B-O O
acids B-O O
is B-O O
not B-O O
maintained B-O O
, B-O O
as B-O O
in B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
, B-O O
or B-O O
in B-O O
yeast B-O O
lysts B-O O
chimera#1 B-O O
and B-O O
yeast B-O O
asnrs B-O O
chimera#2 B-O O
(figure B-O O
5b) B-O O
, B-O O
the B-O O
binding B-O O
to B-O O
trna B-O O
is B-O O
strongly B-O O
affected B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
could B-O O
be B-O O
#decreased B-O B-V
, B-O O
or B-O O
even B-O O
abolished B-O O
in B-O O
the B-O B-A1
case B-O O
of B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
(table) B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
were B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
was B-O O
lowered B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
was B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
was B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O B-A1
rap1 B-O O
mutants B-O O
. B-O O
  
the B-O O
levels B-O B-A1
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
will B-O O
be B-O O
#decreased B-O B-V
in B-O O
nlf B-O O
from B-O O
smokers B-O O
, B-O O
and B-O O
it B-O O
is B-O O
also B-O O
found B-O O
that B-O O
nlf B-O O
from B-O O
smokers B-O O
contained B-O O
increased B-O O
proportions B-O O
of B-O O
a B-O O
truncated B-O O
variant B-O O
of B-O O
lipocortin-1 B-O O
, B-O O
threee B-O O
acidic B-O O
forms B-O O
of B-O O
alpha B-O O
(1)-antitrypsin B-O O
, B-O O
and B-O O
one B-O O
phosphorylated B-O O
form B-O O
of B-O O
cystatin B-O O
s B-O O
.syntrophin B-O O
binds B-O O
to B-O O
an B-O O
alternatively B-O O
spliced B-O O
exon B-O O
of B-O O
dystrophin B-O O
. B-O O
  
the B-O B-A1
production B-O I-A1
of B-O I-A1
c51 B-O I-A1
microcin B-O I-A1
had B-O O
the B-O O
ability B-O O
to B-O O
to B-O O
#decrease B-O B-V
or B-O O
be B-O O
absent B-O O
in B-O O
rpos B-O B-A2
, B-O I-A2
crp B-O I-A2
and B-O I-A2
cya B-O I-A2
mutant B-O I-A2
cells B-O I-A2
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O B-A1
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
were B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
was B-O O
able B-O O
to B-O O
be B-O O
lowered B-O O
and B-O O
levels B-O O
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
was B-O O
able B-O O
to B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
was B-O O
be B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
may B-O O
be B-O O
lowered B-O O
and B-O O
the B-O B-A1
reln B-O I-A1
mrna B-O I-A1
content B-O I-A1
may B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
may B-O O
have B-O O
significantly B-O O
#decreased B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
has B-O O
the B-O O
ability B-O O
to B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
were B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
could B-O O
be B-O O
lowered B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
could B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
was B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O B-A1
rap1 B-O O
mutants B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
could B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
could B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
might B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
might B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
is B-O O
believed B-O O
to B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
may B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
could B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O I-A0
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
will B-O O
be B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
will B-O O
be B-O O
lowered B-O O
and B-O O
methionine B-O B-A1
content B-O I-A1
will B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
will B-O O
be B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
were B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
was B-O O
able B-O O
to B-O O
be B-O O
lowered B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
was B-O O
able B-O O
to B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
was B-O O
be B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O B-A1
rap1 B-O O
mutants B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
is B-O O
shown B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
was B-O O
able B-O O
to B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
the B-O B-A1
production B-O I-A1
of B-O I-A1
c51 B-O I-A1
microcin B-O I-A1
would B-O O
#decrease B-O B-V
or B-O O
be B-O O
absent B-O O
in B-O O
rpos B-O B-A2
, B-O I-A2
crp B-O I-A2
and B-O I-A2
cya B-O I-A2
mutant B-O I-A2
cells B-O I-A2
. B-O O
  
if B-O O
this B-O O
distance B-O O
of B-O O
30 B-O O
amino B-O O
acids B-O O
is B-O O
not B-O O
maintained B-O O
, B-O O
as B-O O
in B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
, B-O O
or B-O O
in B-O O
yeast B-O O
lysts B-O O
chimera#1 B-O O
and B-O O
yeast B-O O
asnrs B-O O
chimera#2 B-O O
(figure B-O O
5b) B-O O
, B-O O
the B-O O
binding B-O O
to B-O O
trna B-O O
is B-O O
strongly B-O O
affected B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
was B-O O
shown B-O O
to B-O O
be B-O O
#decreased B-O B-V
, B-O O
or B-O O
even B-O O
abolished B-O O
in B-O O
the B-O B-A1
case B-O O
of B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
(table) B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
was B-O O
believed B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
might B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O I-A0
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
the B-O B-A1
production B-O I-A1
of B-O I-A1
c51 B-O I-A1
microcin B-O I-A1
was B-O O
able B-O O
to B-O O
#decrease B-O B-V
or B-O O
be B-O O
absent B-O O
in B-O O
rpos B-O B-A2
, B-O I-A2
crp B-O I-A2
and B-O I-A2
cya B-O I-A2
mutant B-O I-A2
cells B-O I-A2
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
was B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
was B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
is B-O O
believed B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
the B-O B-A1
production B-O I-A1
of B-O I-A1
c51 B-O I-A1
microcin B-O I-A1
has B-O O
the B-O O
ability B-O O
to B-O O
to B-O O
#decrease B-O B-V
or B-O O
be B-O O
absent B-O O
in B-O O
rpos B-O B-A2
, B-O I-A2
crp B-O I-A2
and B-O I-A2
cya B-O I-A2
mutant B-O I-A2
cells B-O I-A2
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
can B-O O
have B-O O
been B-O O
lowered B-O O
and B-O O
the B-O B-A1
reln B-O I-A1
mrna B-O I-A1
content B-O I-A1
can B-O O
have B-O O
been B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
is B-O O
able B-O O
to B-O O
be B-O O
lowered B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
is B-O O
able B-O O
to B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
be B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O B-A1
rap1 B-O O
mutants B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
were B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
might B-O O
be B-O O
lowered B-O O
and B-O O
the B-O B-A1
reln B-O I-A1
mrna B-O I-A1
content B-O I-A1
might B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
was B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
if B-O O
this B-O O
distance B-O O
of B-O O
30 B-O O
amino B-O O
acids B-O O
is B-O O
not B-O O
maintained B-O O
, B-O O
as B-O O
in B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
, B-O O
or B-O O
in B-O O
yeast B-O O
lysts B-O O
chimera#1 B-O O
and B-O O
yeast B-O O
asnrs B-O O
chimera#2 B-O O
(figure B-O O
5b) B-O O
, B-O O
the B-O O
binding B-O O
to B-O O
trna B-O O
is B-O O
strongly B-O O
affected B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
is B-O O
believed B-O O
to B-O O
be B-O O
#decreased B-O B-V
, B-O O
or B-O O
even B-O O
abolished B-O O
in B-O O
the B-O B-A1
case B-O O
of B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
(table) B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
is B-O O
able B-O O
to B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
may B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
if B-O O
this B-O O
distance B-O O
of B-O O
30 B-O O
amino B-O O
acids B-O O
is B-O O
not B-O O
maintained B-O O
, B-O O
as B-O O
in B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
, B-O O
or B-O O
in B-O O
yeast B-O O
lysts B-O O
chimera#1 B-O O
and B-O O
yeast B-O O
asnrs B-O O
chimera#2 B-O O
(figure B-O O
5b) B-O O
, B-O O
the B-O O
binding B-O O
to B-O O
trna B-O O
is B-O O
strongly B-O O
affected B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
will B-O O
have B-O O
been B-O O
#decreased B-O B-V
, B-O O
or B-O O
even B-O O
abolished B-O O
in B-O O
the B-O B-A1
case B-O O
of B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
(table) B-O O
. B-O O
  
the B-O B-A1
production B-O I-A1
of B-O I-A1
c51 B-O I-A1
microcin B-O I-A1
#decreases B-O B-V
or B-O O
is B-O O
absent B-O O
in B-O O
rpos B-O B-A2
, B-O I-A2
crp B-O I-A2
and B-O I-A2
cya B-O I-A2
mutant B-O I-A2
cells B-O I-A2
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
could B-O O
be B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
was B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
would B-O O
significantly B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
is B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
is B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
the B-O O
levels B-O B-A1
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
will B-O O
have B-O O
been B-O O
#decreased B-O B-V
in B-O O
nlf B-O O
from B-O O
smokers B-O O
, B-O O
and B-O O
it B-O O
has B-O O
also B-O O
been B-O O
found B-O O
that B-O O
nlf B-O O
from B-O O
smokers B-O O
contained B-O O
increased B-O O
proportions B-O O
of B-O O
a B-O O
truncated B-O O
variant B-O O
of B-O O
lipocortin-1 B-O O
, B-O O
threee B-O O
acidic B-O O
forms B-O O
of B-O O
alpha B-O O
(1)-antitrypsin B-O O
, B-O O
and B-O O
one B-O O
phosphorylated B-O O
form B-O O
of B-O O
cystatin B-O O
s B-O O
.syntrophin B-O O
binds B-O O
to B-O O
an B-O O
alternatively B-O O
spliced B-O O
exon B-O O
of B-O O
dystrophin B-O O
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
might B-O O
be B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
was B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
if B-O O
this B-O O
distance B-O O
of B-O O
30 B-O O
amino B-O O
acids B-O O
is B-O O
not B-O O
maintained B-O O
, B-O O
as B-O O
in B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
, B-O O
or B-O O
in B-O O
yeast B-O O
lysts B-O O
chimera#1 B-O O
and B-O O
yeast B-O O
asnrs B-O O
chimera#2 B-O O
(figure B-O O
5b) B-O O
, B-O O
the B-O O
binding B-O O
to B-O O
trna B-O O
is B-O O
strongly B-O O
affected B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
might B-O O
be B-O O
#decreased B-O B-V
, B-O O
or B-O O
even B-O O
abolished B-O O
in B-O O
the B-O B-A1
case B-O O
of B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
(table) B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
was B-O O
believed B-O O
to B-O O
significantly B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
can B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
was B-O O
believed B-O O
to B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
might B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O B-A1
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
is B-O O
able B-O O
to B-O O
be B-O O
lowered B-O O
and B-O O
levels B-O O
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
is B-O O
able B-O O
to B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
be B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
is B-O O
shown B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
is B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O B-A1
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
were B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
could B-O O
be B-O O
lowered B-O O
and B-O O
levels B-O O
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
could B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
was B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
if B-O O
this B-O O
distance B-O O
of B-O O
30 B-O O
amino B-O O
acids B-O O
is B-O O
not B-O O
maintained B-O O
, B-O O
as B-O O
in B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
, B-O O
or B-O O
in B-O O
yeast B-O O
lysts B-O O
chimera#1 B-O O
and B-O O
yeast B-O O
asnrs B-O O
chimera#2 B-O O
(figure B-O O
5b) B-O O
, B-O O
the B-O O
binding B-O O
to B-O O
trna B-O O
is B-O O
strongly B-O O
affected B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
can B-O O
have B-O O
been B-O O
#decreased B-O B-V
, B-O O
or B-O O
even B-O O
abolished B-O O
in B-O O
the B-O B-A1
case B-O O
of B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
(table) B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
may B-O O
have B-O O
been B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
was B-O O
shown B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
can B-O O
have B-O O
been B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
is B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
may B-O O
have B-O O
been B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
is B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
is B-O O
believed B-O O
to B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
, B-O O
and B-O O
permits B-O O
a B-O O
recovery B-O O
of B-O I-A0
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
in B-O O
brain B-O O
areas B-O O
of B-O O
schizophrenia B-O O
patients B-O O
homologous B-O O
to B-O O
those B-O O
of B-O O
the B-O O
nonpsychiatric B-O O
subjects B-O O
, B-O O
levels B-O B-A1
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
was B-O O
significantly B-O O
#decreased B-O B-V
(4050%; B-O O
see B-O O
table B-O O
2) B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
has B-O O
#decreased B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
might B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
have B-O O
been B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
has B-O O
been B-O O
lowered B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
has B-O O
been B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
has B-O O
been B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O B-A1
rap1 B-O O
mutants B-O O
. B-O O
  
the B-O O
levels B-O B-A1
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
is B-O O
able B-O O
to B-O O
be B-O O
#decreased B-O B-V
in B-O O
nlf B-O O
from B-O O
smokers B-O O
, B-O O
and B-O O
it B-O O
has B-O O
also B-O O
been B-O O
found B-O O
that B-O O
nlf B-O O
from B-O O
smokers B-O O
contained B-O O
increased B-O O
proportions B-O O
of B-O O
a B-O O
truncated B-O O
variant B-O O
of B-O O
lipocortin-1 B-O O
, B-O O
threee B-O O
acidic B-O O
forms B-O O
of B-O O
alpha B-O O
(1)-antitrypsin B-O O
, B-O O
and B-O O
one B-O O
phosphorylated B-O O
form B-O O
of B-O O
cystatin B-O O
s B-O O
.syntrophin B-O O
binds B-O O
to B-O O
an B-O O
alternatively B-O O
spliced B-O O
exon B-O O
of B-O O
dystrophin B-O O
. B-O O
  
the B-O O
levels B-O B-A1
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
could B-O O
be B-O O
#decreased B-O B-V
in B-O O
nlf B-O O
from B-O O
smokers B-O O
, B-O O
and B-O O
it B-O O
has B-O O
also B-O O
been B-O O
found B-O O
that B-O O
nlf B-O O
from B-O O
smokers B-O O
contained B-O O
increased B-O O
proportions B-O O
of B-O O
a B-O O
truncated B-O O
variant B-O O
of B-O O
lipocortin-1 B-O O
, B-O O
threee B-O O
acidic B-O O
forms B-O O
of B-O O
alpha B-O O
(1)-antitrypsin B-O O
, B-O O
and B-O O
one B-O O
phosphorylated B-O O
form B-O O
of B-O O
cystatin B-O O
s B-O O
.syntrophin B-O O
binds B-O O
to B-O O
an B-O O
alternatively B-O O
spliced B-O O
exon B-O O
of B-O O
dystrophin B-O O
. B-O O
  
the B-O O
levels B-O B-A1
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
is B-O O
able B-O O
to B-O O
be B-O O
#decreased B-O B-V
in B-O O
nlf B-O O
from B-O O
smokers B-O O
, B-O O
and B-O O
it B-O O
is B-O O
also B-O O
found B-O O
that B-O O
nlf B-O O
from B-O O
smokers B-O O
contained B-O O
increased B-O O
proportions B-O O
of B-O O
a B-O O
truncated B-O O
variant B-O O
of B-O O
lipocortin-1 B-O O
, B-O O
threee B-O O
acidic B-O O
forms B-O O
of B-O O
alpha B-O O
(1)-antitrypsin B-O O
, B-O O
and B-O O
one B-O O
phosphorylated B-O O
form B-O O
of B-O O
cystatin B-O O
s B-O O
.syntrophin B-O O
binds B-O O
to B-O O
an B-O O
alternatively B-O O
spliced B-O O
exon B-O O
of B-O O
dystrophin B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O B-A1
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
can B-O O
be B-O O
lowered B-O O
and B-O O
levels B-O O
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
can B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
may B-O O
be B-O O
lowered B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
may B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O B-A1
rap1 B-O O
mutants B-O O
. B-O O
  
in B-O O
brain B-O O
areas B-O O
of B-O O
schizophrenia B-O O
patients B-O O
homologous B-O O
to B-O O
those B-O O
of B-O O
the B-O O
nonpsychiatric B-O O
subjects B-O O
, B-O O
the B-O B-A1
reln B-O I-A1
mrna B-O I-A1
content B-O I-A1
was B-O O
significantly B-O O
#decreased B-O B-V
(4050%; B-O O
see B-O O
table B-O O
2) B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
can B-O O
significantly B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
can B-O O
be B-O O
lowered B-O O
and B-O O
methionine B-O B-A1
content B-O I-A1
can B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
were B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
was B-O O
able B-O O
to B-O O
be B-O O
lowered B-O O
and B-O O
methionine B-O B-A1
content B-O I-A1
was B-O O
able B-O O
to B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
was B-O O
be B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
has B-O O
caused B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
have B-O O
significantly B-O O
#decreased B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
were B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
might B-O O
be B-O O
lowered B-O O
and B-O O
methionine B-O B-A1
content B-O I-A1
might B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
was B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
will B-O O
be B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
will B-O O
be B-O O
lowered B-O O
and B-O O
the B-O B-A1
reln B-O I-A1
mrna B-O I-A1
content B-O I-A1
will B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
will B-O O
be B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
the B-O O
levels B-O B-A1
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
will B-O O
be B-O O
#decreased B-O B-V
in B-O O
nlf B-O O
from B-O O
smokers B-O O
, B-O O
and B-O O
it B-O O
has B-O O
also B-O O
been B-O O
found B-O O
that B-O O
nlf B-O O
from B-O O
smokers B-O O
contained B-O O
increased B-O O
proportions B-O O
of B-O O
a B-O O
truncated B-O O
variant B-O O
of B-O O
lipocortin-1 B-O O
, B-O O
threee B-O O
acidic B-O O
forms B-O O
of B-O O
alpha B-O O
(1)-antitrypsin B-O O
, B-O O
and B-O O
one B-O O
phosphorylated B-O O
form B-O O
of B-O O
cystatin B-O O
s B-O O
.syntrophin B-O O
binds B-O O
to B-O O
an B-O O
alternatively B-O O
spliced B-O O
exon B-O O
of B-O O
dystrophin B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
were B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
was B-O O
lowered B-O O
and B-O O
methionine B-O B-A1
content B-O I-A1
was B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
was B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
may B-O O
have B-O O
been B-O O
lowered B-O O
and B-O O
methionine B-O B-A1
content B-O I-A1
may B-O O
have B-O O
been B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
may B-O O
be B-O O
lowered B-O O
and B-O O
methionine B-O B-A1
content B-O I-A1
may B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
if B-O O
this B-O O
distance B-O O
of B-O O
30 B-O O
amino B-O O
acids B-O O
is B-O O
not B-O O
maintained B-O O
, B-O O
as B-O O
in B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
, B-O O
or B-O O
in B-O O
yeast B-O O
lysts B-O O
chimera#1 B-O O
and B-O O
yeast B-O O
asnrs B-O O
chimera#2 B-O O
(figure B-O O
5b) B-O O
, B-O O
the B-O O
binding B-O O
to B-O O
trna B-O O
is B-O O
strongly B-O O
affected B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
will B-O O
be B-O O
#decreased B-O B-V
, B-O O
or B-O O
even B-O O
abolished B-O O
in B-O O
the B-O B-A1
case B-O O
of B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
(table) B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
can B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
, B-O O
and B-O O
permits B-O O
a B-O O
recovery B-O O
of B-O I-A0
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
the B-O B-A1
production B-O I-A1
of B-O I-A1
c51 B-O I-A1
microcin B-O I-A1
is B-O O
shown B-O O
to B-O O
#decrease B-O B-V
or B-O O
be B-O O
absent B-O O
in B-O O
rpos B-O B-A2
, B-O I-A2
crp B-O I-A2
and B-O I-A2
cya B-O I-A2
mutant B-O I-A2
cells B-O I-A2
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
will B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
would B-O O
be B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
was B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
the B-O B-A1
production B-O I-A1
of B-O I-A1
c51 B-O I-A1
microcin B-O I-A1
is B-O O
able B-O O
to B-O O
#decrease B-O B-V
or B-O O
be B-O O
absent B-O O
in B-O O
rpos B-O B-A2
, B-O I-A2
crp B-O I-A2
and B-O I-A2
cya B-O I-A2
mutant B-O I-A2
cells B-O I-A2
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
will B-O O
be B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
will B-O O
have B-O O
been B-O O
lowered B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
will B-O O
have B-O O
been B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
will B-O O
be B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O B-A1
rap1 B-O O
mutants B-O O
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
may B-O O
be B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
is B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
#decreased B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O I-A0
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
is B-O O
able B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
#decreased B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
were B-O O
detected B-O O
(consistent B-O O
with B-O O
lower B-O O
expression B-O O
levels B-O O
and B-O O
#decreased B-O B-V
methionine B-O O
content) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
was B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
significantly B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
#decreases B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O I-A0
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O B-A1
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
can B-O O
have B-O O
been B-O O
lowered B-O O
and B-O O
levels B-O O
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
can B-O O
have B-O O
been B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
will B-O O
have B-O O
#decreased B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
can B-O O
be B-O O
lowered B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
can B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O B-A1
rap1 B-O O
mutants B-O O
. B-O O
  
if B-O O
this B-O O
distance B-O O
of B-O O
30 B-O O
amino B-O O
acids B-O O
is B-O O
not B-O O
maintained B-O O
, B-O O
as B-O O
in B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
, B-O O
or B-O O
in B-O O
yeast B-O O
lysts B-O O
chimera#1 B-O O
and B-O O
yeast B-O O
asnrs B-O O
chimera#2 B-O O
(figure B-O O
5b) B-O O
, B-O O
the B-O O
binding B-O O
to B-O O
trna B-O O
is B-O O
strongly B-O O
affected B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
may B-O O
have B-O O
been B-O O
#decreased B-O B-V
, B-O O
or B-O O
even B-O O
abolished B-O O
in B-O O
the B-O B-A1
case B-O O
of B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
(table) B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
caused B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
significantly B-O O
#decreased B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
. B-O O
  
if B-O O
this B-O O
distance B-O O
of B-O O
30 B-O O
amino B-O O
acids B-O O
is B-O O
not B-O O
maintained B-O O
, B-O O
as B-O O
in B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
, B-O O
or B-O O
in B-O O
yeast B-O O
lysts B-O O
chimera#1 B-O O
and B-O O
yeast B-O O
asnrs B-O O
chimera#2 B-O O
(figure B-O O
5b) B-O O
, B-O O
the B-O O
binding B-O O
to B-O O
trna B-O O
is B-O O
strongly B-O O
affected B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
is B-O O
able B-O O
to B-O O
be B-O O
#decreased B-O B-V
, B-O O
or B-O O
even B-O O
abolished B-O O
in B-O O
the B-O B-A1
case B-O O
of B-O O
human B-O O
asprs B-O O
chimera#1 B-O O
(table) B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
is B-O O
able B-O O
to B-O O
be B-O O
lowered B-O O
and B-O O
the B-O B-A1
reln B-O I-A1
mrna B-O I-A1
content B-O I-A1
is B-O O
able B-O O
to B-O O
be B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
be B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O O
rap1 B-O O
mutants B-O O
. B-O O
  
the B-O O
levels B-O B-A1
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
can B-O O
be B-O O
#decreased B-O B-V
in B-O O
nlf B-O O
from B-O O
smokers B-O O
, B-O O
and B-O O
it B-O O
has B-O O
also B-O O
been B-O O
found B-O O
that B-O O
nlf B-O O
from B-O O
smokers B-O O
contained B-O O
increased B-O O
proportions B-O O
of B-O O
a B-O O
truncated B-O O
variant B-O O
of B-O O
lipocortin-1 B-O O
, B-O O
threee B-O O
acidic B-O O
forms B-O O
of B-O O
alpha B-O O
(1)-antitrypsin B-O O
, B-O O
and B-O O
one B-O O
phosphorylated B-O O
form B-O O
of B-O O
cystatin B-O O
s B-O O
.syntrophin B-O O
binds B-O O
to B-O O
an B-O O
alternatively B-O O
spliced B-O O
exon B-O O
of B-O O
dystrophin B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
is B-O O
believed B-O O
to B-O O
significantly B-O O
#decrease B-O B-V
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A0
the B-O O
nirb B-O O
promoter B-O I-A1
. B-O O
  
the B-O O
levels B-O B-A1
of B-O I-A1
clara B-O I-A1
cell B-O I-A1
secretory B-O I-A1
protein B-O I-A1
has B-O O
been B-O O
#decreased B-O B-V
in B-O O
nlf B-O O
from B-O O
smokers B-O O
, B-O O
and B-O O
it B-O O
has B-O O
also B-O O
been B-O O
found B-O O
that B-O O
nlf B-O O
from B-O O
smokers B-O O
contained B-O O
increased B-O O
proportions B-O O
of B-O O
a B-O O
truncated B-O O
variant B-O O
of B-O O
lipocortin-1 B-O O
, B-O O
threee B-O O
acidic B-O O
forms B-O O
of B-O O
alpha B-O O
(1)-antitrypsin B-O O
, B-O O
and B-O O
one B-O O
phosphorylated B-O O
form B-O O
of B-O O
cystatin B-O O
s B-O O
.syntrophin B-O O
binds B-O O
to B-O O
an B-O O
alternatively B-O O
spliced B-O O
exon B-O O
of B-O O
dystrophin B-O O
. B-O O
  
in B-O O
contrast B-O O
, B-O O
only B-O O
low B-O O
levels B-O O
of B-O O
the B-O O
truncated B-O O
rap1 B-O O
peptides B-O O
are B-O O
detected B-O O
(consistent B-O O
with B-O O
that B-O O
expression B-O O
levels B-O O
can B-O O
have B-O O
been B-O O
lowered B-O O
and B-O O
the B-O B-A1
protection B-O I-A1
can B-O O
have B-O O
been B-O O
decreased) B-O O
, B-O O
and B-O O
neither B-O O
rap2 B-O O
nor B-O O
rap3 B-O O
is B-O O
co-immunoprecipitated B-O O
in B-O O
the B-O B-A1
rap1 B-O O
mutants B-O O
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
can B-O O
be B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
is B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
nitrite B-O B-A1
induction B-O I-A1
of B-O I-A1
the B-O I-A1
nirb B-O I-A1
promoter B-O I-A1
was B-O O
believed B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
disruption B-O B-A0
of B-O I-A0
narl B-O I-A0
which B-O O
was B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
can B-O O
be B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
permits B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
their B-O B-A0
mutation B-O I-A0
causes B-O O
#decreased B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
was B-O O
believed B-O O
to B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
might B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
has B-O O
#decreased B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
might B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
will B-O O
be B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
permits B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
may B-O O
significantly B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
. B-O O
  
their B-O B-A0
mutation B-O I-A0
is B-O O
able B-O O
to B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
their B-O B-A0
mutation B-O I-A0
was B-O O
able B-O O
to B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
their B-O B-A0
mutation B-O I-A0
could B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
promoter B-O B-A1
activity B-O I-A1
might B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
promoter B-O B-A1
activity B-O I-A1
was B-O O
able B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
their B-O B-A0
mutation B-O I-A0
will B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
would B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
can B-O O
have B-O O
significantly B-O O
#decreased B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
caused B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
has B-O O
significantly B-O O
#decreased B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
. B-O O
  
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
is B-O O
believed B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
was B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
could B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
could B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
was B-O O
shown B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
. B-O O
  
in B-O O
brain B-O O
areas B-O O
of B-O O
schizophrenia B-O O
patients B-O O
homologous B-O O
to B-O O
those B-O O
of B-O O
the B-O O
nonpsychiatric B-O O
subjects B-O O
, B-O O
the B-O B-A0
reln B-O I-A0
mrna B-O I-A0
content B-O I-A0
might B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
(4050%; B-O O
see B-O O
table B-O O
2) B-O O
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
may B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
, B-O O
and B-O O
permits B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
would B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
might B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
their B-O B-A0
mutation B-O I-A0
might B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
their B-O B-A0
mutation B-O I-A0
was B-O O
shown B-O O
to B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
in B-O O
brain B-O O
areas B-O O
of B-O O
schizophrenia B-O O
patients B-O O
homologous B-O O
to B-O O
those B-O O
of B-O O
the B-O O
nonpsychiatric B-O O
subjects B-O O
, B-O O
the B-O B-A0
reln B-O I-A0
mrna B-O I-A0
content B-O I-A0
is B-O O
being B-O O
significantly B-O O
#decreasing B-O B-V
(4050%; B-O O
see B-O O
table B-O O
2) B-O O
. B-O O
  
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
may B-O O
have B-O O
been B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
. B-O O
  
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
may B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
might B-O O
be B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
will B-O O
have B-O O
been B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
have B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
is B-O O
able B-O O
to B-O O
significantly B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
caused B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
were B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
could B-O O
significantly B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
their B-O B-A0
mutation B-O I-A0
had B-O O
the B-O O
ability B-O O
to B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
is B-O O
believed B-O O
to B-O O
significantly B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
was B-O O
believed B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
their B-O B-A0
mutation B-O I-A0
#decreased B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
is B-O O
able B-O O
to B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
, B-O O
and B-O O
permits B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
was B-O O
shown B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
caused B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
have B-O O
been B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
their B-O B-A0
mutation B-O I-A0
was B-O O
able B-O O
to B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
could B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
. B-O O
  
in B-O O
brain B-O O
areas B-O O
of B-O O
schizophrenia B-O O
patients B-O O
homologous B-O O
to B-O O
those B-O O
of B-O O
the B-O O
nonpsychiatric B-O O
subjects B-O O
, B-O O
the B-O B-A0
reln B-O I-A0
mrna B-O I-A0
content B-O I-A0
can B-O O
have B-O O
been B-O O
significantly B-O O
#decreased B-O B-V
(4050%; B-O O
see B-O O
table B-O O
2) B-O O
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
their B-O B-A0
mutation B-O I-A0
has B-O O
the B-O O
ability B-O O
to B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
their B-O B-A0
mutation B-O I-A0
would B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
has B-O O
#decreased B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
promoter B-O B-A1
activity B-O I-A1
can B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
may B-O O
have B-O O
been B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
is B-O O
able B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
permits B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
was B-O O
able B-O O
to B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
might B-O O
significantly B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
promoter B-O B-A1
activity B-O I-A1
would B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
has B-O O
been B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
in B-O O
brain B-O O
areas B-O O
of B-O O
schizophrenia B-O O
patients B-O O
homologous B-O O
to B-O O
those B-O O
of B-O O
the B-O O
nonpsychiatric B-O O
subjects B-O O
, B-O O
the B-O B-A0
reln B-O I-A0
mrna B-O I-A0
content B-O I-A0
could B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
(4050%; B-O O
see B-O O
table B-O O
2) B-O O
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
was B-O O
shown B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
promoter B-O B-A1
activity B-O I-A1
is B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
was B-O O
believed B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
is B-O O
able B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
might B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
might B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
will B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
is B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
may B-O O
have B-O O
been B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
have B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
promoter B-O B-A1
activity B-O I-A1
may B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
their B-O B-A0
mutation B-O I-A0
is B-O O
believed B-O O
to B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
in B-O O
brain B-O O
areas B-O O
of B-O O
schizophrenia B-O O
patients B-O O
homologous B-O O
to B-O O
those B-O O
of B-O O
the B-O O
nonpsychiatric B-O O
subjects B-O O
, B-O O
the B-O B-A0
reln B-O I-A0
mrna B-O I-A0
content B-O I-A0
is B-O O
able B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
(4050%; B-O O
see B-O O
table B-O O
2) B-O O
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
is B-O O
believed B-O O
to B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
, B-O O
and B-O O
permits B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
significantly B-O O
#decreases B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
would B-O O
be B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
their B-O B-A0
mutation B-O I-A0
may B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
may B-O O
have B-O O
#decreased B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
promoter B-O B-A1
activity B-O I-A1
was B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
can B-O O
have B-O O
been B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
is B-O O
shown B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
their B-O B-A0
mutation B-O I-A0
#decreased B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
would B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
, B-O O
and B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
their B-O B-A0
mutation B-O I-A0
#decreases B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
can B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
can B-O O
have B-O O
been B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
, B-O O
and B-O O
have B-O O
permitted B-O O
a B-O O
recovery B-O O
of B-O O
both B-O O
reduced B-O O
glutathione B-O O
and B-O O
scavenger B-O O
enzyme B-O O
activity B-O O
. B-O O
  
their B-O B-A0
mutation B-O I-A0
can B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
might B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
their B-O B-A0
mutation B-O I-A0
can B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
in B-O O
brain B-O O
areas B-O O
of B-O O
schizophrenia B-O O
patients B-O O
homologous B-O O
to B-O O
those B-O O
of B-O O
the B-O O
nonpsychiatric B-O O
subjects B-O O
, B-O O
the B-O B-A0
reln B-O I-A0
mrna B-O I-A0
content B-O I-A0
is B-O O
believed B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
(4050%; B-O O
see B-O O
table B-O O
2) B-O O
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
is B-O O
able B-O O
to B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
promoter B-O B-A1
activity B-O I-A1
was B-O O
believed B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
is B-O O
shown B-O O
to B-O O
be B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
has B-O O
the B-O O
ability B-O O
to B-O O
#decrease B-O B-V
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
whilst B-O O
not B-O O
suppressing B-O O
induction B-O O
by B-O O
nitrate B-O O
, B-O O
suggesting B-O O
that B-O O
there B-O O
may B-O O
be B-O O
a B-O O
second B-O O
nitrate-responsive B-O O
factor B-O O
. B-O O
  
deletion B-O O
of B-O O
the B-O O
arca B-O O
gene B-O O
causes B-O O
about B-O O
a B-O O
2-fold B-O O
increase B-O O
in B-O O
the B-O O
ptsg B-O O
expression B-O O
, B-O O
and B-O O
lipid B-O B-A1
peroxide B-O I-A1
synthesis B-O I-A1
are B-O O
significantly B-O O
#decreased B-O B-V
by B-O O
treatment B-O B-A0
with B-O I-A0
melatonin B-O I-A0
will B-O O
significantly B-O O
. B-O O
  
mef2-binding B-O O
sites B-O O
have B-O O
been B-O O
reported B-O O
in B-O O
several B-O O
cardiac B-O O
promoters B-O O
and B-O O
their B-O B-A0
mutation B-O I-A0
would B-O O
#decrease B-O B-V
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
. B-O O
  
promoter B-O B-A1
activity B-O I-A1
in B-O O
cardiomyocytes B-O B-A2
was B-O O
believed B-O O
to B-O O
be B-O O
#decreased B-O B-V
by B-O O
their B-O B-A0
mutation B-O I-A0
. B-O O
  
